Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
News|Articles|April 2, 2003
- Pharmaceutical Technology-04-02-2003
- Volume 27
- Issue 4
Outsourcing Outlook
Author(s)Jim Miller
As demand for contract services slows down, contractors restructure themselves and the industry.
Advertisement
Articles in this issue
over 23 years ago
April 2003over 23 years ago
Identification of Out-of-Trend Stability Resultsover 23 years ago
Overhauling Compliance and GMPsAdvertisement
Related to this article
Advertisement
Advertisement